The Biotech Growth Trust PLC (LON:BIOG) Insider Acquires £10,272 in Stock

The Biotech Growth Trust PLC (LON:BIOG) insider Hamish Baillie bought 1,200 shares of The Biotech Growth Trust stock in a transaction on Thursday, December 19th. The shares were bought at an average cost of GBX 856 ($10.76) per share, with a total value of £10,272 ($12,911.01).

Hamish Baillie also recently made the following trade(s):

• On Wednesday, November 27th, Hamish Baillie purchased 3,000 shares of The Biotech Growth Trust stock. The stock was purchased at an average cost of GBX 931 ($11.70) per share, with a total value of £27,930 ($35,105.58).

The Biotech Growth Trust Trading Up 0.6 %

Shares of The Biotech Growth Trust stock opened at GBX 868 ($10.91) on Monday. The company has a debt-to-equity ratio of 13.03, a current ratio of 0.33 and a quick ratio of 0.00. The Biotech Growth Trust PLC has a 1 year low of GBX 840.94 ($10.57) and a 1 year high of GBX 1,068.36 ($13.43). The firm has a market cap of £278.89 million, a PE ratio of 419.32 and a beta of 0.50. The company has a 50 day simple moving average of GBX 970.52 and a two-hundred day simple moving average of GBX 995.32.

The Biotech Growth Trust Company Profile

The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the biotechnology sector. The fund invests in stocks of companies across all market capitalizations.